Dr Ponchon
ActiveDr Ponchon has been active since 2013 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €297k and a net result of €111k. Equity is growing by ~8.1% per year across the filed fiscal years. Its solvency ranks better than 26% of 16491 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
80
/ 100
Excellent
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability69▲+4
Solvency56▲+8
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €23k at 30 days acceptable
Liquidity ample (current ratio 1.51 against 1.2 in 2024; short-term debt: 19.5% and cash: 26% of total assets), but 69% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
31%
Return on assets
11.6%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 23-04-2026, 99 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
99 d early
2024
147 d early
2023
99 d early
2022
25 d early
2021
3 d late
2020
145 d early
2019
49 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
19-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€297k▲ 35.5%
2024 · €219k
2018: €126k
2019: €175k
2020: €174k
2021: €181k
2022: €135k
2023: €173k
2024: €219k
2018 → 2025
Total assets
€957k▼ 0.6%
2024 · €963k
2018: €557k
2019: €560k
2020: €555k
2021: €542k
2022: €888k
2023: €919k
2024: €963k
2018 → 2025
Net result
€111k▲ 36.3%
2024 · €81k
2018: €71k
2019: €61k
2020: €25k
2021: €7k
2022: €-31k
2023: €67k
2024: €81k
2018 → 2025
Working capital
€95k▲ 123%
2024 · €43k
2018: €29k
2019: €63k
2020: €46k
2021: €5k
2022: €-19k
2023: €10k
2024: €43k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€181k-€135k▼ 25.0%€173k▲ 27.6%€219k▲ 26.7%€297k▲ 35.5%
Operating result€72k-€12k▼ 82.9%€177k▲ 1,341%€167k▼ 5.2%€212k▲ 26.8%
Net result€7k-€-31k€67k€81k▲ 20.4%€111k▲ 36.3%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result recovers in 2025; 2025 is 27% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €957k
Fixed assets
€675k▼ 4.2%
Current assets
€282k▲ 9.2%
Equity and liabilities €957k
Equity
€297k▲ 35.5%
Provisions
€64k▼ 4.3%
Debt
€596k▼ 12.0%
The debt ratio falls from 70.3% to 62.3%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€243k▲
2024 · €198k
Cash flow
€141k▲
2024 · €112k
Solvency
31.0%▲
2024 · 22.7%
Current ratio
1.51▲
2024 · 1.20
Quick ratio
1.51▲
2024 · 1.20
Debt / equity
2.01▼
2024 · 3.09
ROE
37.3%▲
2024 · 37.1%
ROA
11.6%▲
2024 · 8.4%
Interest coverage
4.28▼
2024 · 4.29
Debt
€596k▼
2024 · €677k
Debt ≤ 1 year
€187k▼
2024 · €215k
Debt > 1 year
€409k▼
2024 · €462k
Income taxes
€47k▲
2024 · €44k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€963k€957k▼
Fixed assets21/28€705k€675k▼
Tangible fixed assets22/27€705k€675k▼
Land and buildings22€665k€644k▼
Furniture and vehicles24€5k€3k▼
Other tangible fixed assets26€35k€28k▼
Current assets29/58€258k€282k▲
Amounts receivable within one year40/41€821€2k▲
Other amounts receivable41€821€2k▲
Current investments50/53€26k€26k▼
Cash at bank and in hand54/58€218k€249k▲
Deferred charges and accrued income490/1€14k€5k▼
Equity and liabilities
Total equity and liabilities10/49€963k€957k▼
Equity10/15€219k€297k▲
Contributions10/11€12k€12k=
Reserves13€183k€261k▲
Distributable reserves133€183k€261k▲
Profit (loss) carried forward14€23k€23k=
Provisions and deferred taxes16€67k€64k▼
Provisions for liabilities and charges160/5€67k€64k▼
Other liabilities and charges164/5€67k€64k▼
Amounts payable17/49€677k€596k▼
Amounts payable after more than one year17€462k€409k▼
Financial debts170/4€462k€409k▼
Amounts payable within one year42/48€215k€187k▼
Current portion of amounts payable after more than one year42€52k€52k▲
Financial debts43€1k-
Credit institutions430/8€1k-
Trade debts44€2k€714▼
Suppliers440/4€2k€714▼
Taxes, remuneration and social security45€7k€4k▼
Taxes450/3€5k€4k▼
Remuneration and social security454/9€2k-
Other amounts payable47/48€153k€130k▼
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€31k€31k▼
Provisions for liabilities and charges: additions (uses and reversals)635/8€12k€-3k▼
Other operating charges640/8€3k€4k▲
Non-recurring operating charges66A€207-
Gross operating margin9900€214k€243k▲
Operating profit (loss)9901€167k€212k▲
Financial income75/76B€4k€2k▼
Recurring financial income75€4k€2k▼
Financial charges65/66B€46k€57k▲
Recurring financial charges65€46k€57k▲
Profit (loss) for the period before taxes9903€125k€157k▲
Income taxes67/77€44k€47k▲
Profit (loss) for the period9904€81k€111k▲
Profit (loss) for the period to be appropriated9905€81k€111k▲
Appropriation of the result
Profit (loss) to be appropriated9906€105k€134k▲
Profit (loss) brought forward from the previous period14P€23k€23k=
Transfer from equity791/2€35k€33k▼
Transfer to equity691/2€81k€111k▲
To other reserves6921€81k€111k▲
Profit to be distributed694/7€35k€33k▼
Return on contributions (dividend)694€35k€33k▼
The notes to these accounts (7 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
23-04
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Highest result since 2018net €111k ▲36.3%
Operating result €212k, net result €111k, both a record.
06-03
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Equity above €200kEq €219k ▲26.7%
2 profitable years in a row build equity to €219k.
23-04
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial
Back to profitnet €67k
Net result €67k after one loss-making year.
31-12
Financial
Equity above €150kEq €173k ▲27.6%
Equity rises from €135k to €173k.
06-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial
Weakest financial yearnet €-31k ▼528%
Net result drops to €-31k, the lowest in the series; recovery starts the following year.
03-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 3 days late
2021
08-03
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
18-09
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 49 days late
2019
31-12
Financial
Equity above €150kEq €175k ▲38.5%
2 profitable years in a row build equity to €175k.
03-06
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
10-08
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 10 days late
2017
24-07
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Overijse · 2 establishment units since 2013
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Zonienboslaan 393090 OverijseGround area
1.0 ha
Building footprint
6,934 m²
Volume, LiDAR
117,785 m³
2 parcels, Brussels, Flanders · tallest building 29.7 m, ±6 floors. Linked by address, not a title deed.
2 establishment units
Zonienboslaan 39, 3090 Overijse
since 20132.216.177.806
Linthoutstraat 150, 1040 Etterbeek
since 20172.263.825.788
2 parcels
Flanders
1
(50%)
Brussels
1
(50%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21005A0499/00X007 | Brussels | 9,174 m² | 1 · 6,824 m² | 29.7 m · 6 fl. |
| 23062M0070/00T004 | Flanders | 905 m² | 1 · 110 m² | 8.6 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Legal Entity Identifier
2549009JQFCX3Z49A729
Similar companies · same sector, comparable size
CEO MEDICAL
BE 0475.798.856
Oudergem · Eq €297k
Dokter Vincent Eggerding
BE 0781.304.712
De Haan · Eq €297k
Dr. Erik Ranschaert
BE 0668.403.838
Turnhout · Eq €297k
DR POPPE , YL BRUCHA
BE 0822.384.410
Overijse · Eq €297k
VAN TRIMPONT MEDICAL
BE 0893.210.444
Dinant · Eq €297k
Of 16,627 companies in sector 86220 we hold annual accounts for 7,973. 6,663 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded18-01-2013
Fiscal year end31-12
Activities, NACEBEL
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 13 filingsAddress and cadastre registers
Data from official sources, last processed on 19-09-2026. Scores and ratios are computed by Checked and are not a credit decision.